bluebird bio Inc. (NASDAQ: BLUE) Stock Information | RedChip

bluebird bio Inc. (NASDAQ: BLUE) Listen to this Section


$0.82
-0.2400 ( -22.60% ) 31.9M

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

Market Data


Open


$0.82

Previous close


$1.06

Volume


31.9M

Market cap


$182.68M

Day range


$0.79 - $1.08

52 week range


$0.79 - $5.53

Insider Ownership Transactions

Total Amount Purchased: -74,775.00 | $ -61,322.98

Date Type Amount Purchased Purchaser
2024-06-24 Sale -74775.00 Cloonan Michael

SEC Fillings


Form Type Description Pages Date
nt Quarterly Reports 1 Aug 14, 2024
8-k 8K-related 17 Aug 14, 2024
8-k 8K-related 14 Jul 11, 2024
4 Insider transactions 1 Jul 03, 2024
8-k 8K-related 13 Jun 24, 2024
4 Insider transactions 1 Jun 24, 2024
3 Insider transactions 2 Jun 24, 2024
3 Insider transactions 2 Jun 13, 2024
4 Insider transactions 2 Jun 04, 2024
8-k 8K-related 14 May 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.